Fig. 5From: The tissue origin of human mesenchymal stem cells dictates their therapeutic efficacy on glucose and lipid metabolic disorders in type II diabetic miceThe effects of MSC injection on hepatic functional injury. A, B Representative images of HE-stained liver sections of the indicated groups. Scale bar = 50 μm. Hepatocellular ballooning in the liver of the indicated groups were scored. MET, metformin. After the last time of cell injection, serum concentrations of C AST, D ALT, E AST/ALT ratio, and F ALP were measured. The results are expressed as the means ± S.E.M. n = 6 mice per group. *P<0.05, **P<0.01, ***P<0.001 versus the vehicle group. One-way ANOVABack to article page